# Kyruus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kyruus

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.kyruushealth.com/
- Total disclosed funding: $138M
- Latest round: Series E (Sep 15, 2022)
- Investors on record: 10

## About

Kyruus, Inc., trading under the name Kyruus Health, based in the US, delivers a comprehensive care access platform that optimizes healthcare operations for health systems, hospitals, and payers through advanced provider data management and patient scheduling solutions. Kyruus, Inc. specializes in healthcare access solutions, streamlining operations for various stakeholders. Founded in 2010 in Boston, US, by Graham Gardner, the company has executed 16 deals, with the latest deal in September 2025, RevSpring Payments Inc., a portfolio company of Frazier Healthcare Partners, 22C Capital, and New Enterprise Associates, agreed to acquire Kyruus Health from Gerson Lehrman Group, Inc., Highland Capital Partners, Venrock, Eight Roads Ventures, F-Prime Capital, Lux Capital, Allumia Ventures, McKesson Ventures, New Leaf Venture Partners, Transformation Capital, Salesforce Ventures, Francisco Partners, UPMC Enterprises, and Echo Health Ventures. The deal was completed in October 2025. Kyruus Health focuses on a comprehensive care access platform that enhances healthcare operations for health systems, hospitals, medical groups, and payers. Core offerings include solutions for provider data management, patient scheduling, and digital intake processes, all designed to efficiently connect patients with the appropriate healthcare providers. Kyruus Health serves various clients across the US, including health plans and government programs, facilitating improved patient experiences and operational efficiencies. Kyruus Health primarily operates on a B2B model, generating revenue through subscription-based agreements and partnerships with healthcare organizations. Clients engage with Kyruus for a suite of services, including the Kyruus Connect platform, which integrates healthcare data and enhances patient interactions. Revenue structures involve annual licensing fees for software and potential service fees for additional support, with specific pricing plans tailored to client needs, supported by robust analytics capabilities that drive decision-making and care optimization.

## Funding rounds

- Series E, Sep 15, 2022, $35M — Francisco Partners, Highland Capital Partners, New Leaf Venture Partners, Allumia Ventures, Echo Health Ventures
- Series D, Jun 12, 2020, $30M — Francisco Partners
- Series D, Dec 6, 2019, $42M — Highland Capital Partners, Venrock, Salesforce Ventures, Allumia Ventures
- Series C, Oct 9, 2018, $4M — Salesforce Ventures
- Series C, Apr 3, 2018, $10M — Allumia Ventures
- Series B, Jan 2, 2013, $11M — Highland Capital Partners, Venrock, F-Prime Capital, Lux Capital
- Series A, Jun 21, 2011, $5.5M — Highland Capital Partners, Venrock, Gerson Lehrman Group, Inc.

## Investors

- Highland Capital Partners (https://capitalatlas.ai/funds/highland-capital-partners) — Series A, Series B, Series D, Series E
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B, Series D
- Gerson Lehrman Group, Inc. — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series B
- Allumia Ventures (https://capitalatlas.ai/funds/allumia-ventures) — Series C, Series D, Series E
- Salesforce Ventures (https://capitalatlas.ai/funds/salesforce-ventures) — Series C, Series D
- Francisco Partners (https://capitalatlas.ai/funds/francisco-partners) — Series D, Series E
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series E
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series E